Khure Health

Cardiovascular disease (CVD) remains a leading cause of death globally. Early detection and appropriate management are crucial for improving patient outcomes and reducing the burden of CVD. Khure Health, in partnership with WELL Health, is revolutionizing cardiovascular care by integrating our AI-powered Clinical Co-Pilot into WELL's AI Decision Support (WAIDS) platform. 

The WAIDS - Cardiology Co-Pilot utilizes advanced artificial intelligence to analyze the wealth of clinical data already residing within your Electronic Medical Record (EMR) to support you clinically.  This data often remains untapped.  Our Co-Pilot harnesses your EMR data’s potential to help you identify patients at risk for various cardiovascular conditions or in potential need of optimization to guidelines.

The WAIDS Cardiology Co-Pilot provides valuable insights to cardiologists, leading to potentially earlier detection of a wide range of cardiovascular conditions or clinical guideline adherence support, including HFrEF, HFpEF, Primary Hyperaldosteronism, Obstructive Hypertrophic Cardiomyopathy, Aortic Stenosis, Hereditary ATTR Amyloidosis-CM, Fabry Disease, Loeys-Dietz Syndrome, and many others. Early detection and intervention lead to better outcomes, preventing complications and less clinical burden on you. 

WAIDS is fully compliant with all federal and provincial privacy regulations and ensures the complete security of your patient data. 

https://healwell.ai/well-health-launches-its-ai-powered-co-pilot-for-cardiologists-powered-by-healwell-ai-to-help-improve-detection-of-cardiovascular-disease/